Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 8
2008 10
2009 7
2010 13
2011 12
2012 12
2013 13
2014 15
2015 15
2016 15
2017 12
2018 16
2019 20
2020 11
2021 19
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

174 results
Results by year
Filters applied: . Clear all
Page 1
Central nervous system complications associated with immune checkpoint inhibitors.
Vogrig A, Muñiz-Castrillo S, Joubert B, Picard G, Rogemond V, Marchal C, Chiappa AM, Chanson E, Skowron F, Leblanc A, Ducray F, Honnorat J. Vogrig A, et al. Among authors: ducray f. J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):772-778. doi: 10.1136/jnnp-2020-323055. Epub 2020 Apr 20. J Neurol Neurosurg Psychiatry. 2020. PMID: 32312871
The molecular landscape of glioma in patients with Neurofibromatosis 1.
D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D, Cangiano M, Capelle L, de Groot J, DiMeco F, Ducray F, Farah W, Finocchiaro G, Goutagny S, Kamiya-Matsuoka C, Lavarino C, Loiseau H, Lorgis V, Marras CE, McCutcheon I, Nam DH, Ronchi S, Saletti V, Seizeur R, Slopis J, Suñol M, Vandenbos F, Varlet P, Vidaud D, Watts C, Tabar V, Reuss DE, Kim SK, Meyronet D, Mokhtari K, Salvador H, Bhat KP, Eoli M, Sanson M, Lasorella A, Iavarone A. D'Angelo F, et al. Among authors: ducray f. Nat Med. 2019 Jan;25(1):176-187. doi: 10.1038/s41591-018-0263-8. Epub 2018 Dec 10. Nat Med. 2019. PMID: 30531922 Free PMC article.
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
Appay R, Dehais C, Maurage CA, Alentorn A, Carpentier C, Colin C, Ducray F, Escande F, Idbaih A, Kamoun A, Marie Y, Mokhtari K, Tabouret E, Trabelsi N, Uro-Coste E, Delattre JY, Figarella-Branger D; POLA Network. Appay R, et al. Among authors: ducray f. Neuro Oncol. 2019 Dec 17;21(12):1519-1528. doi: 10.1093/neuonc/noz124. Neuro Oncol. 2019. PMID: 31832685 Free PMC article.
Letter to the Editor.
Meyronet D, Ducray F. Meyronet D, et al. Among authors: ducray f. Neuro Oncol. 2019 Nov 4;21(11):1482. doi: 10.1093/neuonc/noz161. Neuro Oncol. 2019. PMID: 31648295 Free PMC article. No abstract available.
Prognostic markers in gliomas.
Labussiere M, Wang XW, Idbaih A, Ducray F, Sanson M. Labussiere M, et al. Among authors: ducray f. Future Oncol. 2010 May;6(5):733-9. doi: 10.2217/fon.10.25. Future Oncol. 2010. PMID: 20465388 Review.
Chemotherapy in low-grade gliomas.
Viaccoz A, Lekoubou A, Ducray F. Viaccoz A, et al. Among authors: ducray f. Curr Opin Oncol. 2012 Nov;24(6):694-701. doi: 10.1097/CCO.0b013e328357f503. Curr Opin Oncol. 2012. PMID: 22913972 Review.
[Biology of gliomas].
Ducray F. Ducray F. Cancer Radiother. 2008 Nov;12(6-7):663-8. doi: 10.1016/j.canrad.2008.09.001. Epub 2008 Oct 1. Cancer Radiother. 2008. PMID: 18838326 Review. French.
Anaplastic gliomas in adults: an update.
Izquierdo C, Joubert B, Ducray F. Izquierdo C, et al. Among authors: ducray f. Curr Opin Oncol. 2017 Nov;29(6):434-442. doi: 10.1097/CCO.0000000000000409. Curr Opin Oncol. 2017. PMID: 28901965 Review.
An Overview of Intracranial Ependymomas in Adults.
Lombardi G, Della Puppa A, Pizzi M, Cerretti G, Bonaudo C, Gardiman MP, Dipasquale A, Gregucci F, Esposito A, De Bartolo D, Zagonel V, Simonelli M, Fiorentino A, Ducray F. Lombardi G, et al. Among authors: ducray f. Cancers (Basel). 2021 Dec 5;13(23):6128. doi: 10.3390/cancers13236128. Cancers (Basel). 2021. PMID: 34885237 Free PMC article. Review.
Primary brain tumours in adults.
Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K, Delattre JY. Ricard D, et al. Among authors: ducray f. Lancet. 2012 May 26;379(9830):1984-96. doi: 10.1016/S0140-6736(11)61346-9. Epub 2012 Apr 16. Lancet. 2012. PMID: 22510398 Review.
174 results